PASG logo
NASDAQ · PASGBiotechnologyUpdated Nov 2, 2026

Passage Bio, Inc. ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Passage Bio, Inc. (PASG) is -218.59%

According to Passage Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -218.59%. This represents a change of 161.81% compared to the average of -83.49% of the last 4 quarters.

Passage Bio, Inc. (PASG) Historical ROE (quarterly & annually)

How has PASG ROE performed in the past?

The mean historical ROE of Passage Bio, Inc. over the last ten years is -65.50%. The current -218.59% ROE has changed 233.70% with respect to the historical average. Over the past ten years (40 quarters), PASG's ROE was at its highest in in the June 2019 quarter at 0%. The ROE was at its lowest in in the June 2026 quarter at -175.52%.

Quarterly (TTM)
Annual

Average

-65.50%

Median

-62.89%

Minimum

-242.72%

Maximum

104.90%

Passage Bio, Inc. (PASG) ROE by Quarter and Year

Discovering the peaks and valleys of Passage Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 129.58%

Maximum Annual ROE = 104.90%

Minimum Annual Increase = -124.95%

Minimum Annual ROE = -242.72%

Quarterly (TTM)
Annual
YearROEChange
2025-242.72%129.58%
2024-105.72%15.27%
2023-91.71%35.67%
2022-67.60%16.20%
2021-58.18%57.95%
2020-36.83%40.72%
2019-26.17%-124.95%

Passage Bio, Inc. (PASG) Average ROE

How has PASG ROE performed in the past?

The current ROE of Passage Bio, Inc. (PASG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-146.72%

5-year avg

-113.19%

10-year avg

-65.50%

Passage Bio, Inc. (PASG) ROE vs. Peers

How is PASG’s ROE compared to its peers?

Passage Bio, Inc.’s ROE is greater than NuCana plc (-41.95%), greater than MetaVia Inc. (-209.67%), greater than Lisata Therapeutics, Inc. (-113.79%), greater than Allarity Therapeutics, Inc. (-152.77%), greater than CytoMed Therapeutics Limited (-91.37%), less than Enlivex Therapeutics Ltd. (211.00%), greater than Cingulate Inc. (-238.41%), greater than CollPlant Biotechnologies Ltd. (-215.58%), greater than Exicure, Inc. (-237.91%), less than CASI Pharmaceuticals, Inc. (96.40%),

Build a custom stock screener for Passage Bio, Inc. (PASG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Passage Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Passage Bio, Inc. (PASG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Passage Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Passage Bio, Inc.'s ROE?

How is the ROE calculated for Passage Bio, Inc. (PASG)?

What is the highest ROE for Passage Bio, Inc. (PASG)?

What is the 3-year average ROE for Passage Bio, Inc. (PASG)?

What is the 5-year average ROE for Passage Bio, Inc. (PASG)?

How does the current ROE for Passage Bio, Inc. (PASG) compare to its historical average?